Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2025 09:00 ET | Source: BIOXYTRAN, INC.

Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M

BOSTON, MASSACHUSETTS, May 12, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing novel antiviral therapies, today announced...
February 21, 2024 08:00 ET | Source: BIOXYTRAN, INC.

Bioxytran’s Oral Antiviral Drug to Enter Dose Optimization Clinical Trial for COVID-19

First Medicinal chemistry of an antiviral drug made of sugars BOSTON, MASSACHUSETTS, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT), (the “Company”), a clinical stage biotechnology...
September 25, 2023 14:40 ET | Source: Zion Market Research

Radiation Dose Management Market Size Will Attain USD 7.77 Billion by 2030 Registering a Promising CAGR of 4.79% - Exclusive Report by Zion Market Research

NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Radiation Dose Management Market By Modality (Computed Tomography,...